Apoptosis in Cultured Human Colon Cancer Cells Induced by Combined Treatments wtih 5-Fluorouracil, Tumor Necrosis Factor-α and Interferon-α

Japanese Journal of Clinical Oncology

Volumn 27, Issue 4, 1997, Pages 231-235

  Oka, Yoshinari ^a   Naomoto, Yoshio ^a   Yasuoka, Yasuo ^a   Hatano, Hiroaki ^a   Haisa, Minoru ^a   Tanaka, Noriaki ^a   Orita, Kunzo ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

5 fluorouracil; Apoptosis; Interferon ; Tumor necrosis factor

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; COLORING AGENT; DIAGNOSTIC AGENT; DNA NUCLEOTIDYLEXOTRANSFERASE; FLUOROURACIL; METHYL GREEN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; COLON TUMOR; COMPARATIVE STUDY; DRUG EFFECT; GIEMSA STAIN; HUMAN; PATHOLOGY;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; AZURE STAINS; CELL SURVIVAL; COLONIC NEOPLASMS; COLORING AGENTS; DNA NUCLEOTIDYLEXOTRANSFERASE; FLUOROURACIL; HUMANS; INTERFERON-ALPHA; METHYL GREEN; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031202388     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.4.231     Document Type: Article

References (27)

1. Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R et al. Fluorinated pyrimidines, a new class of tumor-inhibitory compounds. Nature 1957;179:663-6.
2. Wadler S, Schwartz EL. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review Cancer Res 1990;50:3473-86.
3. Le J, Yip YK, Vilcek J. Cytolytic activity of interferon-gamma and its synergism with 5-fluorouracil. Int J Cancer 1984;34:495-500.
4. Sparano JA, Wadler S, Liebes L, Robert NJ, Schwartz EL, Dutcher JP. Phase I trial of cyclophosphamide, doxorubicin and 5-fluorouracil plus interferon-α 2b in patients with advanced breast cancer. Cancer Res 53:1993;3509-12.
5. Wadler S, Goldman M, Lyver A, Wiernik PH. Phase I trial of 5-fluorouracil and recombinant α 2a-interferon in patients with advanced colorectal carcinoma. Cancer Res 1990;50:2056-9.
6. Chu E, Koeller DM, Johnston PG, Zinn S, Allegra CI. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-γ. Molecular Pharmacol 1993;43:527-33.
7. Chu E, Zinn S, Boarman D, Allegra CJ Interaction of γ Interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 1990;50:5831-40.
8. Wadler S, Schwartz EL, Wersto R, Thompson D, Wiernik PH. Interferon modulates the activity of 5-fluorouracil against two human colon cancer cell lines. Proc Am Assoc Cancer Res 1989;30:569.
9. Stolfi RL, Martin DS, Sawyer RC, Spiegelman S. Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid. Cancer Res 1983;43:561-6
10. Kerr JFR, Wyllie AH, Currie AR Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
11. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
12. Wright SC, Kumar P, Tam AW, Shen N, Varma M, Larrick JW. Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U 937 cells. J Cell Biochem 1992,48.344-55
13. Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 1988;141:2629-34.
14. Rubin BY, Smith LJ, Hellermann GR, Lunn RM, Richardson NK, Anderson SL. Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res 1988;48:6006-10.
15. Kyprianou N, Alexander RB, Isaacs JT. Activation of programmed cell death by recombinant human tumor necrosis factor plus topoisomerase II-targeted drugs in L 929 tumor cells. J Natl Cancer Inst 1991;83:346-50.
16. Shinagawa T, Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y et al. Apoptosis in cultured rat hepatocytes: the effect of tumor necrosis factor a and interferon γ. J Pathol 1991;165:247-53.
17. Dealtry GB, Naylor MS, Fiers W, Balkwill FR. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by Interferon-γ. Eur J Immunol 1987;17:689-93.
18. Tanaka N, Ohoida J, Matuno T, Gouchi A, Iwagaki H, Moreira LF et al. Response of adenosquamous carcinoma of the pancreas to interferon-alpha, tumor necrosis factor-alpha and 5-fluorouracil combined treatment. Anti-cancer Res 1994;14(6B):2739-42.
19. Kreuser ED, Wadler S, Thiel E. Biochemical modulation of cytotoxic drugs by cytokines: molecular mechanisms in experimental oncology. Recent Results Cancer Res 1995;139:371-82.
20. Naomoto Y, Tanaka N, Fuchimoto S, Orita K. In vitro synergistic effect of natural tumor necrosis factor-α and natural interferon-α. Jpn J Cancer Res 1987;78:87-92.
21. Muro M, Naomoto Y, Orita K. Mechanism of the combined tumor necrosis factor-a and interferon-a on cell cycle progression. Jpn J Cancer Res 1991;82:118-26.
22. Satomoto K, Haisa M, Naomoto Y, Tanaka N, Orita K. Cyclin A and Cdk2 kinase activity are suppressed by combined treatment with tumor necrosis factor-α and interferon-α. Biochem Biophys Res Commun, in press.
23. Elias I, Sandoval JM. Interferon effects upon fluorouracil metabolism by HL-60 cells. Biochem Biophys Res Commun 1989;163:867-74.
24. Schwartz EL, Hoffman M, O'Connor CJ, Wadler S. Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cells. Biochem Biophys Res Commun 1989;182:1232-9.
25. Hatano H, Tanaka N, Naomoto Y, Orita K. Suppressive effect of TNF-α on increased production of FdUMP by IFN-α Res Comm Mol Pathol Pharmacol. in press.
26. Chu E, Zinn S, Boarman D, Allegra CJ. Interaction of γ Interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 1990, 50:5834-40.
27. Akazawa S. Biochemical modulation of 5-FU with interferon. Gan to Kagaku Ryoho 1992;19:963-9.